zotepine has been researched along with Behavior Disorders in 4 studies
zotepine: structure
| Excerpt | Relevance | Reference |
|---|---|---|
| "This paper incorporates data on placebo-controlled studies of zotepine as well as studies with comparator compounds also beyond the diagnostic boarder of schizophrenia regarding zotepine's safety." | 8.86 | Safety evaluation of zotepine for the treatment of schizophrenia. ( Möller, HJ; Musil, R; Riedel, M; Schennach-Wolff, R; Seemüller, F; Spellmann, I, 2010) |
| "This paper incorporates data on placebo-controlled studies of zotepine as well as studies with comparator compounds also beyond the diagnostic boarder of schizophrenia regarding zotepine's safety." | 4.86 | Safety evaluation of zotepine for the treatment of schizophrenia. ( Möller, HJ; Musil, R; Riedel, M; Schennach-Wolff, R; Seemüller, F; Spellmann, I, 2010) |
| " (3) Zotepine decreased serum uric acid level parallel with its dosage (r=0." | 1.26 | [Effects of zotepine, a psychotropic agent, on the serum uric acid level of inpatients at a psychiatric hospital]. ( Kaiya, H; Kondo, T; Sanpei, F; Takeda, N; Takeuchi, K; Yoshida, H, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Obara, K | 1 |
| Matsuoka, Y | 1 |
| Iwata, N | 1 |
| Abe, Y | 1 |
| Ikegami, Y | 1 |
| Shioda, N | 1 |
| Hattori, Y | 1 |
| Hamamatsu, S | 1 |
| Yoshioka, K | 1 |
| Yamaki, F | 1 |
| Matsuo, K | 1 |
| Yoshio, T | 1 |
| Tanaka, Y | 1 |
| Riedel, M | 1 |
| Musil, R | 1 |
| Seemüller, F | 1 |
| Spellmann, I | 1 |
| Möller, HJ | 1 |
| Schennach-Wolff, R | 1 |
| Rainer, MK | 1 |
| Krüger-Rainer, C | 1 |
| Haushofer, M | 1 |
| Mucke, HA | 1 |
| Yoshida, H | 1 |
| Kaiya, H | 1 |
| Kondo, T | 1 |
| Sanpei, F | 1 |
| Takeda, N | 1 |
| Takeuchi, K | 1 |
1 review available for zotepine and Behavior Disorders
| Article | Year |
|---|---|
Safety evaluation of zotepine for the treatment of schizophrenia.
Topics: Antipsychotic Agents; Dibenzothiepins; Female; Humans; Male; Mental Disorders; Randomized Controlled | 2010 |
3 other studies available for zotepine and Behavior Disorders
| Article | Year |
|---|---|
Inhibitory Effects of Antipsychotics on the Contractile Response to Acetylcholine in Rat Urinary Bladder Smooth Muscles.
Topics: Acetylcholine; Aging; Animals; Antipsychotic Agents; Chlorpromazine; Cholinergic Antagonists; Clozap | 2021 |
Zotepine for behavioural and psychological symptoms in dementia: an open-label study.
Topics: Alzheimer Disease; Antipsychotic Agents; Dibenzothiepins; Humans; Mental Disorders; Psychiatric Stat | 2004 |
[Effects of zotepine, a psychotropic agent, on the serum uric acid level of inpatients at a psychiatric hospital].
Topics: Adult; Antipsychotic Agents; Creatinine; Dibenzothiepins; Female; Humans; Male; Mental Disorders; Mi | 1982 |